Overview
- The volume brings together clinical and preclinical research literatures
- A balanced view of the potential risks and benefits of these compounds is presented
- The focus is on rigorous scientific findings in a field that has been fraught with speculative reports
Part of the book series: Current Topics in Behavioral Neurosciences (CTBN, volume 36)
Buy print copy
Tax calculation will be finalised at checkout
Table of contents (15 chapters)
Keywords
About this book
Reviews
Editors and Affiliations
Bibliographic Information
Book Title: Behavioral Neurobiology of Psychedelic Drugs
Editors: Adam L. Halberstadt, Franz X. Vollenweider, David E. Nichols
Series Title: Current Topics in Behavioral Neurosciences
DOI: https://doi.org/10.1007/978-3-662-55880-5
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer-Verlag GmbH Germany, part of Springer Nature 2018
Hardcover ISBN: 978-3-662-55878-2Published: 11 April 2018
Softcover ISBN: 978-3-662-58563-4Published: 19 January 2019
eBook ISBN: 978-3-662-55880-5Published: 27 March 2018
Series ISSN: 1866-3370
Series E-ISSN: 1866-3389
Edition Number: 1
Number of Pages: X, 430
Number of Illustrations: 38 b/w illustrations, 158 illustrations in colour
Topics: Neurosciences, Psychopharmacology, Medicinal Chemistry